Miseq reagents
Ended Awarded Last action
- Contract number
- HHSF22301020T
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $138,939
Award facts
- Contract value 100% obligated
- $138,938.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration awarded a $138,938.83 firm fixed-price delivery order to Illumina, Inc. on November 19, 2014, for MiSeq reagents, with a completion date of December 31, 2014. This delivery order, which carries no set-aside designation, represents procurement of consumable reagent kits for the MiSeq DNA sequencing platform. The award to the San Diego-based biotechnology company reflects FDA's reliance on Illumina's specialized genetic sequencing technologies to support the agency's genomic research and diagnostic initiatives. As a delivery order, this contract likely derives from a larger indefinite delivery vehicle or blanket purchase agreement that streamlines procurement processes for consumable products needed across FDA laboratory operations.
Illumina maintains an extensive portfolio of federal contracts across civilian and defense agencies, including a significant $45 million indefinite delivery contract with the U.S. Department of Agriculture that extends through 2030. The company's dominant market position in next-generation sequencing systems and associated reagents positions it as a preferred or sole-source provider for many federal laboratories conducting infectious disease research, genomic diagnostics, and scientific analysis. This FDA delivery order exemplifies the routine procurement activity occurring under Illumina's broader federal contracting relationships, enabling government research facilities to access critical genomic sequencing capabilities and consumables essential for contemporary molecular diagnostics and biological research operations.
Quick answers
Who was awarded contract HHSF22301020T?
HHSF22301020T was awarded to Illumina, Inc. by Food and Drug Administration (Department of Health and Human Services) on November 19, 2014.
How much is contract HHSF22301020T worth?
The government has obligated $138,939 on HHSF22301020T.
Is contract HHSF22301020T an order under another contract?
Yes. HHSF22301020T is a delivery order under HHSF223201210031I, an indefinite delivery contract.
Was contract HHSF22301020T competed?
The extent of competition for HHSF22301020T was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award